Epstein-Barr virus in pediatric patients after renal transplantation

Clinical Nephrology

Volumn 53, Issue 2, 2000, Pages 132-139

  Schwab, M ^a,b   Boswald M ^b   Korn, K ^c   Ruder, H ^b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

EBV DNA; EBV infection; Post transplantation lymphoproliferative disease; Renal transplantation

Indexed keywords

VIRUS CAPSID ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; INFECTION RISK; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHODGKIN LYMPHOMA; SERODIAGNOSIS; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 0343986296     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B 1997 Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 10: 136-145
2. Boyle GJ, Michaels MG, Webber SA, Knisely AS, Kurland G. Cipriani LA, Griffith BP, Fricker FJ 1997 Post-transplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 131: 309-313
3. Breinig MK, Zitelli B, Starzl TE, Ho M 1987 Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 156: 273-279
4. Cen H, Breinig MC, Atchison RW, Ho M, McKnight JL 1991 Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 65: 976-980
5. Ciancio G, Siquijor AP, Burke GW, Roth D, Cirocco R, Esquenazi V, Byrne GE Jr, Miller J 1997 Post-lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. Clin Transplant 11: 243-249
6. Cinque P, Brytting M, Vago L, Castagna A, Parravicini C. Zanchetta N. D'Arminio Monforte A, Wahren B, Lazzarin A, Lindé A 1993 Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342: 398-401
7. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R. Lennette ET. Martinez OM, Krams SM, Berquist WK. So SKS, Esquivel CO 1995 An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 59: 524-529
8. Craig FE, Gulley ML, Banks PM 1993 Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 99: 265-276
9. Crompton CH, Cheung RK, Donjon C, Miyazaki I, Feinmesser R, Hébert D, Dosch H-M 1994 Epstein-Barr virus surveillance after renal transplantation. Transplantation 57: 1182-1189
10. Denning DW, Weiss LM. Martinez K. Flechner SM 1989 Transmission of Epstein-Barr virus by a transplanted kidney, with activation by OKT3 antibody. Transplantation 48: 141-144
11. Fishman JA, Rubin RH 1998 Infection in organ-transplant recipients. N Engl J Med 338: 1741-1751
12. Fleisher G, Bolognese R 1983 Persistent Epstein-Barr virus infection and pregnancy. J Infect Dis 147: 982-986
13. Haque T, Thomas JA, Parratt R, Hunt BJ, Yacoub MH, Crawford DH 1997 A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation 64: 1028-1034
14. Henle W, Henle G 1981 Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 41: 4222-4225
15. Ho M, Jaffe R, Miller G, Breining MK, Dummer JS, Makowha L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE 1988 The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45: 719-727
16. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA 1995 Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 60: 547-554
17. Keown PA 1994 Complications of cyclosporine. In: Tejani AH, Fine RN (eds) Pediatric Renal Transplantation. Wiley-Liss, New York, pp 315-336
18. Korn K, Ruder H. Stenglein S, Gheith S 1992 Incidence of symptomatic viral infections in children and adolescents after renal transplantation. Transplant Proc 24: 2639-2640
19. Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emanuel DJ 1998 Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91: 3654-3661
20. Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR 1996 Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 62: 370-375
21. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT 1991 Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4: 129-135
22. Olson GB, Kanaan MN, Gersuk GM, Kelley LM, Jones JF 1986 Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients. J Allergy Clin Immunol 78: 308-314
23. Opelz G, Henderson R, for the Collaborative Transplant Study 1993 Incidence of non-Hogkin lymphoma in kidney and heart transplant recipients. Lancet 342: 1514-1516
24. Penn I, First MR 1986 Development and incidence of cancer following cyclosporine therapy. Transplant Proc 18 (Suppl 1): 210-215
25. Rickinson AB 1986 Chronic, symptomatic Epstein-Barr virus infection, Immunol Today 7: 13-14
26. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C 1994 Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83: 2715-2722
27. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB 1993 Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 56: 1394-1398
28. Sokal EM, Antunes H, Beguin C, Bodeus M, Wallemacq P, de Ville de Gayet J, Reding R, Janssen M, Buts JP, Otte JB 1997 Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative disease in pediatric liver transplant recipients treated with tacrolimus. Transplantation 64: 1438-1442
29. Sumaya CT, Jenson HB 1992 Epstein-Barr virus. In: Rose N, DeMacario E, Fahey J, Friedman H, Penn G (eds) Manual of Clinical Laboratory Immunology (4th ed). ASM, Washington, DC. pp 568-575
30. Straus SE, Fleisher GR 1989 Infectious mononucleosis. epidemiology and pathogenesis. In: Schlossberg D (ed) Infectious Mononucleosis (2nd ed). Springer, Berlin, pp 8-28
31. Thorley-Lawson DA 1988 Basic virological aspects of Epstein-Barr virus infection. Semin Haematol 25: 247-260